ivabradine has been researched along with natriuretic peptide, brain in 20 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | ivabradine (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 16 (80.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockert, M; Gams, E; Langenbach, MR; Pomblum, VJ; Schepan, M; Schipke, JD; Schmitz-Spanke, S; Zirngibl, H | 1 |
| Clark, AL; Cleland, JG; Coletta, AP; Cullington, D | 1 |
| Kanorskiĭ, SG; Pokrovskiĭ, VM; Tregubov, VG | 1 |
| Henderson, RA; Timmis, AD | 1 |
| Cowie, MR | 1 |
| Málek, F | 1 |
| Holland, DJ; Kosmala, W; Marwick, TH; Przewlocka-Kosmala, M; Rojek, A; Wright, L | 1 |
| Longo, S; Lousada, N; Palma dos Reis, R; Sargento, L; Satendra, M | 1 |
| dos Reis, RP; Longo, S; Lousada, N; Sargento, L; Satendra, M | 1 |
| Martinka, P; Stöckl, G; Zugck, C | 1 |
| Alihanoglu, YI; Evrengul, H; Kaftan, HA; Ordu, S; Ozhan, H; Ozsoy, A; Tosun, M; Yildiz, BS | 1 |
| Ashrafian, H; Dawson, DK; Dwight, JS; Francis, JM; Frenneaux, M; Mahmod, M; Neubauer, S; Pal, N; Rudd, A; Singh, S; Sivaswamy, N; Watkins, H; Yavari, A | 1 |
| Fichtlscherer, S; Fischer-Rasokat, U; Hamm, CW; Honold, J; Liebetrau, C; Lochmann, D; Möllmann, H; Spyridopoulos, I; Wolter, S | 1 |
| Acconcia, MC; Barillà, F; Dominici, T; Gaudio, C; Mangieri, E; Martino, F; Pannarale, G; Pannitteri, G; Paravati, V; Tanzilli, G; Torromeo, C | 1 |
| Bertomeu-González, V; Bertomeu-Martínez, V; Bodí, V; Bosch, MJ; Chorro, FJ; Cordero, A; Fácila, L; Gallego, J; García-Blas, S; Llàcer, A; Llàcer, P; Mendizábal, A; Merlos, P; Miñana, G; Montagud, V; Morell, S; Núñez, J; Palau, P; Pedrosa, V; Sanchis, J; Santas, E | 1 |
| Borisenko, YV; Kanorsky, SG | 1 |
| Fragasso, G; Gemma, M; Godino, C; Margonato, A; Montanaro, C; Pinto, G; Salerno, A; Slavich, M; Spoladore, R; Tondi, L | 1 |
| Imamura, T; Kinugawa, K; Onoda, H; Uchida, K | 1 |
| Amrawy, AME; Dogheim, GM; El-Haggar, SM; Khairat, I; Omran, GA; Werida, RH | 1 |
1 review(s) available for ivabradine and natriuretic peptide, brain
| Article | Year |
|---|---|
[Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
Topics: Acetanilides; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Cardiology; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Ivabradine; Natriuretic Agents; Natriuretic Peptide, Brain; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Risk Factors; Treatment Outcome | 2012 |
11 trial(s) available for ivabradine and natriuretic peptide, brain
| Article | Year |
|---|---|
[Alternative therapy with ivabradine in patients with functional class III chronic heart failure].
Topics: Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Agents; Chronic Disease; Drug Monitoring; Drug Therapy, Combination; Echocardiography; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Severity of Illness Index; Treatment Outcome | 2011 |
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
Topics: Aged; Benzazepines; Blood Flow Velocity; Cardiotonic Agents; Diastole; Double-Blind Method; Echocardiography, Doppler, Pulsed; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Mitral Valve; Natriuretic Peptide, Brain; Oxygen Consumption; Prospective Studies; Ventricular Function, Left; Ventricular Pressure | 2013 |
Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Quality of Life; Treatment Outcome | 2014 |
Effects of ivabradine therapy on heart failure biomarkers.
Topics: Aged; Benzazepines; Biomarkers; CA-125 Antigen; Cardiovascular Agents; Cystatin C; Down-Regulation; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Turkey; Ventricular Function, Left | 2015 |
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction.
Topics: Aged; Aged, 80 and over; Asymptomatic Diseases; Benzazepines; Biomarkers; Cross-Over Studies; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Endpoint Determination; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Oxygen Consumption; Sinoatrial Node; Stroke Volume; Treatment Failure | 2015 |
β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Coronary Artery Disease; Drug Substitution; Dyspnea; Exercise Test; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Ivabradine in Patients with ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock: A Preliminary Randomized Prospective Study.
Topics: Acute Disease; Adult; Aged; Benzazepines; Cardiovascular Agents; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Ventricular Function, Left | 2016 |
Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; CA-125 Antigen; Cardiac Pacing, Artificial; Cardiovascular Agents; Cause of Death; Defibrillators, Implantable; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Monitoring, Physiologic; Mortality; Myocardial Revascularization; Natriuretic Peptide, Brain; Patient Care Planning; Patient Readmission; Peptide Fragments; Sodium Potassium Chloride Symporter Inhibitors; Spain; Treatment Outcome | 2016 |
[Comparative Evaluation of -blockers and If-Channel Inhibitor in Patients With Chronic Heart Failure and Preserved Left Ventricular Ejection Fraction].
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Benzazepines; Bisoprolol; Cardiovascular Agents; Exercise Tolerance; Female; Heart Failure; Heart Ventricles; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Quality of Life; Stroke Volume; Ventricular Function, Left | 2016 |
Implication of Ivabradine Therapy in Up-Titrating Beta-Blocker Dose in Patients with Systolic Dysfunction.
Topics: Adrenergic beta-Antagonists; Biomarkers; Cardiovascular Agents; Echocardiography; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Systole; Walk Test | 2021 |
Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients.
Topics: Anti-Arrhythmia Agents; Biomarkers; Chronic Disease; Diuretics; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, Brain; Neopterin; Stroke Volume | 2022 |
8 other study(ies) available for ivabradine and natriuretic peptide, brain
| Article | Year |
|---|---|
Comparison of a beta-blocker and an If current inhibitor in rabbits with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Aorta; Benzazepines; Blood Flow Velocity; Cardiotonic Agents; Coronary Circulation; Disease Models, Animal; Electrocardiography; Heart Rate; Heart Ventricles; Ivabradine; Male; Metoprolol; Myocardial Contraction; Myocardial Infarction; Natriuretic Peptide, Brain; Oxygen Consumption; Potassium Channel Blockers; Rabbits; Time Factors; Ventricular Function, Left; Ventricular Myosins | 2006 |
Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.
Topics: Benzazepines; Biomarkers; Cardiology; Europe; Fatty Acids, Unsaturated; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Natriuretic Peptide, Brain; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Societies, Medical; Sulfonamides | 2008 |
Recent developments in the management of heart failure.
Topics: Algorithms; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Eplerenone; Heart Failure; Humans; Ivabradine; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Patient Care Team; Peptide Fragments; Spironolactone; Ventricular Dysfunction, Left | 2012 |
[Effect of ivabradin on heart rate, left ventricular function a NT-proBNP concentration in patients with systolic chronic heart failure--case reports].
Topics: Adult; Aged; Benzazepines; Chronic Disease; Cyclic Nucleotide-Gated Cation Channels; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Function, Left; Ventricular Remodeling | 2012 |
[Effect of ivabradine on heart rate, left ventricular function and levels of NT-proBNP in patients with chronic systolic heart failure--case reports].
Topics: Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Function, Left | 2012 |
Early NT-proBNP decrease with ivabradine in ambulatory patients with systolic heart failure.
Topics: Aged; Ambulatory Care; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Drug Therapy, Combination; Female; Heart Failure, Systolic; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prospective Studies; Stroke Volume; Time Factors; Treatment Outcome; Up-Regulation; Ventricular Function, Left | 2013 |
Heart rate reduction with ivabradine in patients with acute decompensated systolic heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Blood Pressure; Female; Heart Failure, Systolic; Heart Rate; Humans; Intensive Care Units; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Time Factors | 2014 |
Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiovascular Agents; Chronic Disease; Echocardiography; Female; Heart Failure, Systolic; Heart Rate; Hospitalization; Humans; Ivabradine; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2018 |